Danaher's net profit rose sharply in Q3 2026 while the operating margin barely moved

Danaher, a US group that makes life-science and diagnostic instruments, reported revenue of USD 6.6bn in Q3 2026 (consolidated, US GAAP, USD), up 8.3% from USD 6.1bn a year earlier. Operating profit reached USD 1.2bn, up 7.9%. Net profit rose far faster, to USD 1.2bn from USD 908m. The net margin widened by 3.8 pp to 18.8%, while the operating margin moved by only 0.1 pp to 19.0%.

When the operating margin barely moves and the net margin jumps, the gain sits below the operating line. That usually means lower financing costs, a smaller tax charge or one-off items. The figures do not say which one applies here. Meanwhile the equity ratio fell by 6.4 pp to 57.5%, as total assets grew faster than equity, to USD 93.3bn from USD 79.9bn. I would look at what sits between operating profit and net profit before calling this stronger earning power.